Phillip Low is a Neurology physician affiliated with Mayo Clinic. OpenAlex indexes 643 publications with 54,019 citations (h-index 116); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 1 May 2026.
Clinical trials
- Mesenchymal Stem Cell Therapy in Multiple System Atrophy
Sponsor: Mayo Clinic
- Study of Rifampicin in Multiple System Atrophy
Sponsor: Phillip Low
- Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Sponsor: Chelsea Therapeutics
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Aprecia Pharmaceuticals, LLCProgram year20211 payment
- Merck Sharp & Dohme CorporationProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
12 NIH research awards on record, funded 1985–2019 per NIH RePORTER. The latest:
- Multiple System Atrophy - Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach
Mayo Clinic Rochester
FY2019$575,041R01NS092625 - Multiple System Atrophy - Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach
Mayo Clinic Rochester
FY2018$559,929R01NS092625 - Multiple System Atrophy - Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach
Mayo Clinic Rochester
FY2017$561,241R01NS092625
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
Movement Disorders
2022 - Autonomic dysfunction following COVID-19 infection: an early experience
Clinical Autonomic Research
2021
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”